Sohag university hospital
Sohag, Sahag, Egypt
Location status: Recruiting
Location contact
Magdy M Ameen, Professor
CONTACT
NCT Number: NCT06715215
Immune thrombocytopenia (ITP) are antibody-mediated disorders in which platelets are destroyed mainly through activating immunoglobulin (IgG) Fc receptors on phagocytes in the spleen and liver, eventually resulting in thrombocytopenia Acute phase proteins (APP) are inflammation markers that exhibit significant changes in serum concentration during inflammation. These are also important mediators produced in the liver during acute and chronic inflammatory states. Acute phase reactants can be classified as positive or negative, depending on their serum concentrations during inflammation. Positive acute phase reactants are upregulated, and their concentrations increase during inflammation. Negative acute phase reactants are downregulated, and their concentrations decrease during inflammation. Positive acute phase proteins include procalcitonin, C-reactive protein, ferritin, fibrinogen, hepcidin, and serum amyloid A. Negative acute phase reactants include albumin, prealbumin, transferrin, retinol-binding protein, and antithrombin CRP is now well established as a major acute phase protein and is used in daily clinical practice as a sensitive biomarker for infection and inflammation, with its level increasing from <0.05 to >500 mg/L after acute infections. CRP is produced by hepatocytes, in response to inflammatory cytokines such as interleukin (IL)-6 and IL-1, with serum concentrations rising to >5 mg/L after 6 hours and peaking after ∼48 hours. In healthy young adult volunteer blood donors, the median concentration of CRP was found to be ∼0.8 mg/L CRP levels are useful as a clinical diagnostic tool for infection, and it is a common knowledge that ITP is triggered by viral infection that precedes the clinical picture of ITP by a few days to a few weeks Procalcitonin (PCT) is used as a reliable inflammatory biomarker with high sensitivity and specificity ferritin was confirmed as an inflammation and infection biomarker in the diagnosis of viral and bacterial infections.
Interested in participating?
Request Info1 year–50 year
All sexes
Interventional
Not applicable
Sohag, Sahag, Egypt
Location status: Recruiting
Magdy M Ameen, Professor
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age of patients : from 1 year to 50 years.
Exclusion criteria
Assessment of acute phase proteins levels in patients diagnosed with immune thrombocytopenia
Time frame: 2 years
By taking serum samples from pateints and measure acute phase proteins levels
Contact information is provided by the study sponsor or research team.
Eman H Ali, Assistant Professor
CONTACT
Rana M Abd Elhameed, Resident
CONTACT
Sohag University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07587723
Autoimmune Diseases, Blood Coagulation Disorders
Basel, Switzerland
View Trial DetailsNCT07104565
Autoimmune Diseases, Blood Coagulation Disorders
Glendale, Arizona, United States
View Trial DetailsNCT07007962
Autoimmune Diseases, Blood Coagulation Disorders
Clovis, California, United States
View Trial DetailsNCT07657793
Autoimmune Diseases, Blood Coagulation Disorders
Beijing, Beijing Municipality, China
View Trial Details